Effect of vitamin D vaginal suppository on sexual functioning among postmenopausal women: A three-arm randomized controlled clinical trial

Vaginal atrophy, the second most common complication of menopause, can lead to sexual dysfunction. This study evaluated the effect of a vitamin D vaginal suppository on sexual functioning in postmenopausal women. This three-arm randomized controlled trial was conducted between August 2019 and August...

Full description

Saved in:
Bibliographic Details
Published inObstetrics & gynecology science Vol. 66; no. 3; pp. 208 - 220
Main Authors Sarebani, Zinat, Chegini, Venus, Chen, Hui, Aali, Ehsan, Mirzadeh, Monirsadat, Abbaspour, Mohammadreza, Griffiths, Mark D, Alimoradi, Zainab
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Society of Obstetrics and Gynecology 01.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Vaginal atrophy, the second most common complication of menopause, can lead to sexual dysfunction. This study evaluated the effect of a vitamin D vaginal suppository on sexual functioning in postmenopausal women. This three-arm randomized controlled trial was conducted between August 2019 and August 2020. The sample comprised 105 postmenopausal women who were referred to comprehensive health service centers to receive postmenopausal care. The inclusion criteria were as follows: (i) being menopausal for at least 1 year, (ii) being married, (iii) being sexually active, and (iv) having sexual desire. Participants were randomly assigned to three groups for 8 weeks of treatment: intervention (vaginal suppository containing 1,000 units of vitamin D3), placebo (vaginal suppository placebo), or control (no treatment). The main outcome measure was sexual functioning, which was assessed using the Female Sexual Function Scale (FSFI) 4 times during the study (i.e., 1 month before the intervention, immediately after the intervention, 1 month after the intervention, and 2 months after the intervention). Immediately and 1 month after the trial, the intervention group had the highest FSFI score, followed by the placebo group, both of which were significantly higher than those of the control group (P<0.05). At the 2-month follow-up, the intervention and placebo groups had similar FSFI scores (P=0.08), both of which were significantly higher than those in the control group (P=0.001 and P=0.03, respectively). Vitamin D vaginal suppositories were more effective at improving sexual functioning among postmenopausal women in the short-term and appeared to prevent aging-related sexual functioning decline in the long term.
AbstractList Objective Vaginal atrophy, the second most common complication of menopause, can lead to sexual dysfunction. This study evaluated the effect of a vitamin D vaginal suppository on sexual functioning in postmenopausal women. Methods This three-arm randomized controlled trial was conducted between August 2019 and August 2020. The sample comprised 105 postmenopausal women who were referred to comprehensive health service centers to receive postmenopausal care. The inclusion criteria were as follows: (i) being menopausal for at least 1 year, (ii) being married, (iii) being sexually active, and (iv) having sexual desire. Participants were randomly assigned to three groups for 8 weeks of treatment: intervention (vaginal suppository containing 1,000 units of vitamin D3), placebo (vaginal suppository placebo), or control (no treatment). The main outcome measure was sexual functioning, which was assessed using the Female Sexual Function Scale (FSFI) 4 times during the study (i.e., 1 month before the intervention, immediately after the intervention, 1 month after the intervention, and 2 months after the intervention). Results Immediately and 1 month after the trial, the intervention group had the highest FSFI score, followed by the placebo group, both of which were significantly higher than those of the control group (P<0.05). At the 2-month follow-up, the intervention and placebo groups had similar FSFI scores (P=0.08), both of which were significantly higher than those in the control group (P=0.001 and P=0.03, respectively). Conclusion Vitamin D vaginal suppositories were more effective at improving sexual functioning among postmenopausal women in the short-term and appeared to prevent aging-related sexual functioning decline in the long term.
Vaginal atrophy, the second most common complication of menopause, can lead to sexual dysfunction. This study evaluated the effect of a vitamin D vaginal suppository on sexual functioning in postmenopausal women. This three-arm randomized controlled trial was conducted between August 2019 and August 2020. The sample comprised 105 postmenopausal women who were referred to comprehensive health service centers to receive postmenopausal care. The inclusion criteria were as follows: (i) being menopausal for at least 1 year, (ii) being married, (iii) being sexually active, and (iv) having sexual desire. Participants were randomly assigned to three groups for 8 weeks of treatment: intervention (vaginal suppository containing 1,000 units of vitamin D3), placebo (vaginal suppository placebo), or control (no treatment). The main outcome measure was sexual functioning, which was assessed using the Female Sexual Function Scale (FSFI) 4 times during the study (i.e., 1 month before the intervention, immediately after the intervention, 1 month after the intervention, and 2 months after the intervention). Immediately and 1 month after the trial, the intervention group had the highest FSFI score, followed by the placebo group, both of which were significantly higher than those of the control group (P<0.05). At the 2-month follow-up, the intervention and placebo groups had similar FSFI scores (P=0.08), both of which were significantly higher than those in the control group (P=0.001 and P=0.03, respectively). Vitamin D vaginal suppositories were more effective at improving sexual functioning among postmenopausal women in the short-term and appeared to prevent aging-related sexual functioning decline in the long term.
Vaginal atrophy, the second most common complication of menopause, can lead to sexual dysfunction. This study evaluated the effect of a vitamin D vaginal suppository on sexual functioning in postmenopausal women.OBJECTIVEVaginal atrophy, the second most common complication of menopause, can lead to sexual dysfunction. This study evaluated the effect of a vitamin D vaginal suppository on sexual functioning in postmenopausal women.This three-arm randomized controlled trial was conducted between August 2019 and August 2020. The sample comprised 105 postmenopausal women who were referred to comprehensive health service centers to receive postmenopausal care. The inclusion criteria were as follows: (i) being menopausal for at least 1 year, (ii) being married, (iii) being sexually active, and (iv) having sexual desire. Participants were randomly assigned to three groups for 8 weeks of treatment: intervention (vaginal suppository containing 1,000 units of vitamin D3), placebo (vaginal suppository placebo), or control (no treatment). The main outcome measure was sexual functioning, which was assessed using the Female Sexual Function Scale (FSFI) 4 times during the study (i.e., 1 month before the intervention, immediately after the intervention, 1 month after the intervention, and 2 months after the intervention).METHODSThis three-arm randomized controlled trial was conducted between August 2019 and August 2020. The sample comprised 105 postmenopausal women who were referred to comprehensive health service centers to receive postmenopausal care. The inclusion criteria were as follows: (i) being menopausal for at least 1 year, (ii) being married, (iii) being sexually active, and (iv) having sexual desire. Participants were randomly assigned to three groups for 8 weeks of treatment: intervention (vaginal suppository containing 1,000 units of vitamin D3), placebo (vaginal suppository placebo), or control (no treatment). The main outcome measure was sexual functioning, which was assessed using the Female Sexual Function Scale (FSFI) 4 times during the study (i.e., 1 month before the intervention, immediately after the intervention, 1 month after the intervention, and 2 months after the intervention).Immediately and 1 month after the trial, the intervention group had the highest FSFI score, followed by the placebo group, both of which were significantly higher than those of the control group (P<0.05). At the 2-month follow-up, the intervention and placebo groups had similar FSFI scores (P=0.08), both of which were significantly higher than those in the control group (P=0.001 and P=0.03, respectively).RESULTSImmediately and 1 month after the trial, the intervention group had the highest FSFI score, followed by the placebo group, both of which were significantly higher than those of the control group (P<0.05). At the 2-month follow-up, the intervention and placebo groups had similar FSFI scores (P=0.08), both of which were significantly higher than those in the control group (P=0.001 and P=0.03, respectively).Vitamin D vaginal suppositories were more effective at improving sexual functioning among postmenopausal women in the short-term and appeared to prevent aging-related sexual functioning decline in the long term.CONCLUSIONVitamin D vaginal suppositories were more effective at improving sexual functioning among postmenopausal women in the short-term and appeared to prevent aging-related sexual functioning decline in the long term.
Author Sarebani, Zinat
Alimoradi, Zainab
Chen, Hui
Aali, Ehsan
Abbaspour, Mohammadreza
Chegini, Venus
Griffiths, Mark D
Mirzadeh, Monirsadat
AuthorAffiliation 4 School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 Students research committee, School of Nursing & Midwifery, University of Technology Sydney, Vltimo, Australia
2 Department Obstetrics and Gynecology School of Medicine, University of Technology Sydney, Vltimo, Australia
5 Metabolic disease research Center, Mashhad University of Medical Sciences, Mashhad, Iran
8 Social Determinants of Health Research Center, Research Institue for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
3 School of Life Sciences, Faculty of Science, University of Technology Sydney, Vltimo, Australia
7 Psychology Department, Nottingham Trent University, Nottingham, UK
6 Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
AuthorAffiliation_xml – name: 4 School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
– name: 2 Department Obstetrics and Gynecology School of Medicine, University of Technology Sydney, Vltimo, Australia
– name: 3 School of Life Sciences, Faculty of Science, University of Technology Sydney, Vltimo, Australia
– name: 7 Psychology Department, Nottingham Trent University, Nottingham, UK
– name: 6 Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
– name: 5 Metabolic disease research Center, Mashhad University of Medical Sciences, Mashhad, Iran
– name: 8 Social Determinants of Health Research Center, Research Institue for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
– name: 1 Students research committee, School of Nursing & Midwifery, University of Technology Sydney, Vltimo, Australia
Author_xml – sequence: 1
  givenname: Zinat
  surname: Sarebani
  fullname: Sarebani, Zinat
  organization: Students research committee, School of Nursing & Midwifery, University of Technology Sydney, Vltimo, Australia
– sequence: 2
  givenname: Venus
  surname: Chegini
  fullname: Chegini, Venus
  organization: Department Obstetrics and Gynecology School of Medicine, University of Technology Sydney, Vltimo, Australia
– sequence: 3
  givenname: Hui
  surname: Chen
  fullname: Chen, Hui
  organization: School of Life Sciences, Faculty of Science, University of Technology Sydney, Vltimo, Australia
– sequence: 4
  givenname: Ehsan
  surname: Aali
  fullname: Aali, Ehsan
  organization: School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
– sequence: 5
  givenname: Monirsadat
  surname: Mirzadeh
  fullname: Mirzadeh, Monirsadat
  organization: Metabolic disease research Center, Mashhad University of Medical Sciences, Mashhad, Iran
– sequence: 6
  givenname: Mohammadreza
  surname: Abbaspour
  fullname: Abbaspour, Mohammadreza
  organization: Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
– sequence: 7
  givenname: Mark D
  surname: Griffiths
  fullname: Griffiths, Mark D
  organization: Psychology Department, Nottingham Trent University, Nottingham, UK
– sequence: 8
  givenname: Zainab
  surname: Alimoradi
  fullname: Alimoradi, Zainab
  organization: Social Determinants of Health Research Center, Research Institue for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36825329$$D View this record in MEDLINE/PubMed
BookMark eNpVkU1vFiEQx4mpsbX24BcwHL1s5XVhvZimVm3SxIueN7MsbGlYeAT20foR_NSirY0lgRlm_vwmzDxHBzFFi9BLSk6l6PWbtJRTxgjXT9ARY1p1Wmpy8OArdohOSrkhbWlJtRbP0CHvNZOcDUfo14Vz1lScHN77CquP-D3ew-IjBFy23S4VX1O-xSniYn9sLeq2aKpP0ccFw5ra2UR1tTHtYCtN8D21y1t8hut1traDvOIMcU6r_2lnbFKsOYXwxw0-etNe1OwhvEBPHYRiT-7tMfr64eLL-afu6vPHy_Ozq84IpWrHQZF-kBOIftbEaDUPnFLpyAQc5okrxXpDKOXgJAUxTXLQgktobXGT0xM_Rpd33DnBzbjLfoV8Oybw499AyssIuXoT7Dhw44wVVgyOtW2gZ9NgesaFmolg0Fjv7li7bVrtbGz7G4RH0MeZ6K_HJe1HSuhAldSN8PqekNO3zZY6rr4YGwJEm7YyMqUJ6bXmpElf_V_socq_afLfNtGnGg
CitedBy_id crossref_primary_10_3390_nu15122815
crossref_primary_10_5468_ogs_24282
crossref_primary_10_3390_nu15173804
crossref_primary_10_1016_j_maturitas_2024_108055
crossref_primary_10_5993_AJHB_48_6_13
crossref_primary_10_1002_ijgo_15106
ContentType Journal Article
Copyright Copyright © 2023 Korean Society of Obstetrics and Gynecology 2023
Copyright_xml – notice: Copyright © 2023 Korean Society of Obstetrics and Gynecology 2023
DBID NPM
7X8
5PM
DOA
DOI 10.5468/ogs.22038
DatabaseName PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2287-8580
EndPage 220
ExternalDocumentID oai_doaj_org_article_93cfce4e49f249fca62b9c62347d042a
PMC10191758
36825329
Genre Journal Article
GrantInformation_xml – fundername: Qazvin University of Medical Sciences
GroupedDBID 5-W
8JR
8XY
ACYCR
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
DIK
EF.
GROUPED_DOAJ
HYE
HZB
KQ8
M48
NPM
PGMZT
RPM
7X8
5PM
ID FETCH-LOGICAL-c477t-3a70695ba46d80c87d93115f0ba3adb37726c0113af51a4bb598435a858fbf8b3
IEDL.DBID M48
ISSN 2287-8572
IngestDate Wed Aug 27 01:32:43 EDT 2025
Thu Aug 21 18:37:13 EDT 2025
Fri Jul 11 06:22:59 EDT 2025
Thu Jan 02 22:51:28 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Postmenopausal period, women
Vitamin D
Vaginal suppository
Sexual function
Language English
License Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c477t-3a70695ba46d80c87d93115f0ba3adb37726c0113af51a4bb598435a858fbf8b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contribute equally as first author.
ORCID 0000-0001-5327-2411
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.5468/ogs.22038
PMID 36825329
PQID 2780068830
PQPubID 23479
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_93cfce4e49f249fca62b9c62347d042a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10191758
proquest_miscellaneous_2780068830
pubmed_primary_36825329
PublicationCentury 2000
PublicationDate 2023-05-01
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Obstetrics & gynecology science
PublicationTitleAlternate Obstet Gynecol Sci
PublicationYear 2023
Publisher Korean Society of Obstetrics and Gynecology
Publisher_xml – name: Korean Society of Obstetrics and Gynecology
SSID ssj0000851884
Score 2.2780964
Snippet Vaginal atrophy, the second most common complication of menopause, can lead to sexual dysfunction. This study evaluated the effect of a vitamin D vaginal...
Objective Vaginal atrophy, the second most common complication of menopause, can lead to sexual dysfunction. This study evaluated the effect of a vitamin D...
SourceID doaj
pubmedcentral
proquest
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 208
SubjectTerms Original
postmenopausal period
sexual function
vaginal suppository
vitamin d
women
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4s1CQUbiapr4EY97K4-qQionKvUW-QmL2KTa7FaCn8CvZmwHtIuQuHCLEksZ-bMz88Uz3xDy0hjHTYqJeW4Ck8oKZpJSDGMH2yhorea5dvj8Q3d2Id9fqsudVl85J6zKA9eJOzLCJx9llCYhU0jedtwZj05b6oALroRG6PN2yNSXmn3VQmk3zJESMFCaV1khJTs4Gj9Nrzhvck1KEer_W3T5Z5Lkjtc5vUNuz-EiPalm3iU34nCP3DyfD8Tvkx9VfZiOiV4jy18tB_qWXtvS64pO26uSkzWuv9FxoFNRV6bZk81_YWlpNURxUM41R_q8nXBAEWU4pid0gzhHZtcrig4tjKvl9xjonNv-NV_OVZW0tP54QC5O3318c8bm9grMS603TFjddEY5K7sAjQcdTJbeSY2zwgYnMO7uPG5_YZNqrXROGcDgyoKC5BI48ZAcDOMQHxMqWzDet0HECNJyD0Eb8JA8si0rg1yQ13me-6uqoNFnTetyA5HuZ6T7fyG9IC9-odTjHsgHG3aI43bquYZc6gKiWZBHFbXfrxIdcmDBzYLAHp57tuw_GZafi842fq2QzCp48j-sf0pu5U71NVfykBxs1tv4DOOZjXtelu5P6er3lQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Effect of vitamin D vaginal suppository on sexual functioning among postmenopausal women: A three-arm randomized controlled clinical trial
URI https://www.ncbi.nlm.nih.gov/pubmed/36825329
https://www.proquest.com/docview/2780068830
https://pubmed.ncbi.nlm.nih.gov/PMC10191758
https://doaj.org/article/93cfce4e49f249fca62b9c62347d042a
Volume 66
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLVKkapuEG-GR2UkthkyfsTXbFB5VBXSsGKk7iI_y6BOUpKZivIJfDXXTgYxqCt2UWIrkW9sn2Nfn0PIK60t0zHEwjHtCyENL3SUskDsYEoJM6NYOjs8_1ydLsSnM3m2R7Yem2MD9jdSu-Qntegupj--X7_FDo_4dSpFBa_b837KWMnhFrmNE5JKRgbzEeV_G1KxZpC9hxnygwKkYoPG0G7tQ3LAKyRMPMHNLOB_E-r8N3nyr9no5C65M8JIejzE_R7ZC819cjAfN8ofkF-DKjFtI71C9r9aNvQDvTLZA4v2m8ucq9V217RtaJ9Vl2ma4cbVWZotiCgWSjnoSKs3PRbIYg1v6DFdY_xDYboVxYnOt6vlz-DpmPN-kS7H05Y0W4I8JIuTj1_enxaj7ULhhFLrghtVVlpaIyoPpQPldZLkiaU13HjLEY9XDocFbqKcGWGt1ICgy4CEaCNY_ojsN20TnhAqZqCdm3keAgjDHHilwUF0yMKM8GJC3qV2ri8HZY06aV3nG213Xo9dp9bcRRdEEDoiV4zOVMxqh7BNKI9DjpmQl9so1dg30oaHaUK76WumIB2BAV5OyOMhan9etQ31hMBOPHe-ZfdJs_ya9bdxFEOSK-Hp_1d9Rg6Tb_2QOfmc7K-7TXiB6GZtj_KqwFH-g38D55P-5Q
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+vitamin+D+vaginal+suppository+on+sexual+functioning+among+postmenopausal+women%3A+A+three-arm+randomized+controlled+clinical+trial&rft.jtitle=Obstetrics+%26+gynecology+science&rft.au=Sarebani%2C+Zinat&rft.au=Chegini%2C+Venus&rft.au=Chen%2C+Hui&rft.au=Aali%2C+Ehsan&rft.date=2023-05-01&rft.pub=Korean+Society+of+Obstetrics+and+Gynecology&rft.issn=2287-8572&rft.eissn=2287-8580&rft.volume=66&rft.issue=3&rft.spage=208&rft.epage=220&rft_id=info:doi/10.5468%2Fogs.22038&rft_id=info%3Apmid%2F36825329&rft.externalDocID=PMC10191758
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-8572&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-8572&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-8572&client=summon